Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00002261 | A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers | PHASE1 | COMPLETED | - | — | — | - | - | Sep 26, 2007 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| Smallpox Vaccine | BIOLOGICAL | - |
| HIVAC-1e | BIOLOGICAL | - |
| gp160 Vaccine (MicroGeneSys) | BIOLOGICAL | - |
Inclusion Criteria Concurrent Medication: Allowed: * All drugs, medications, and therapy which, by virtue of direct pharmacologic action or possible drug interaction, could influence the intended effects of the study vaccine or mask its side effects may be concomitantly administered only by presc...